Secrets and pies: the battle to get lab-grown meat on the menu

Sustainable alternatives to livestock farming are being held back by patents, a reluctance to share research and lack of government supportNot a week goes by without Elliot Swartz receiving at least one request from researchers asking him where they can find cell lines (a cell culture developed from a single cell) for use in cellular agriculture – an essential tool for creating lab-grown meat. “One of the most important things that cell lines offer is that they enable researchers to just get started in this new field,” says Swartz, who works in New York as a senior scientist at theGood Food Institute (GFI) – a nonprofit focused on advancing cellular agriculture and bringing its products to our shelves and stomachs as quickly as possible. Helping researchers is a core part of his role. In the case of cell lines, however, there’s very little he can do.Swartz ’s response to the researchers is unfortunately always the same: at the moment, publicly available cell lines relevant for cellular agriculture don’t really exist. That doesn’t mean that they’re nowhere to be found. Upside Foods (previously Memphis Meats) has submitted several patents to pro tect cell lines it has developed, and companies such asCell Farm Food Tech have built a business around selling cell lines for profit. Keeping discoveries behind closed doors is a pattern of behaviour found in private companies across the industry, which many believe is slowing down ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Stem cells Biology Research and development Meat industry Food Technology Science Source Type: news

Related Links:

TheEli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLAhas been awarded $5 million by the California Institute for Regenerative Medicine, the state ’s stem cell agency, to train young scientists and physicians to become leaders in the stem cell and regenerative medicine field.The five-year grant will enable the center to expand its Stem Cell Training Program, which was established in 2006 and funded by CIRM until 2015, when the agency changed its funding priorities. Since then, the program has been sustained by philanthropy. With the passage of Proposition 14 last fall, however, CIRM ha...
Source: UCLA Newsroom: Health Sciences - Category: Universities & Medical Training Source Type: news
Conclusiones: Se logró establecer un protocolo de aislamiento y expansión celular, con alta tasa de éxito de una población de DPSCh.Resumo Objetivos: Estabelecer e implementar um protocolo simplificado para a extra ção, isolamento primário e cultura de células-tronco da polpa dentária humana (DPSCh). Analise as células isoladas quantitativa e qualitativamente. Metodologia: 10 terceiros molares saudáveis ​ ​ doados por pacientes que frequentaram a Faculdade de Odontologia UdelaR e deram consentimento por escrito foram processados ​ ​ antes ...
Source: Odontoestomatologia - Category: Dentistry Source Type: research
Condition:   Plasma Cell Leukemia Intervention:   Drug: Daratumumab Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: - Category: Research Source Type: clinical trials
One platform, 70 diseases and $72 million — these underpin the launch of Garuda Therapeutics, a new stem cell startup founded by Harvard professor Dhvanit Shah.
Source: Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Conclusion: Rapid tumor CD133 detection and selectivity were demonstrated in vitro and in vivo with PET using the specific CD133 binding peptide 68Ga-DOTA-LS7. A robust correlation was detected in vivo between tumor signals from mouse xenograft models with different cell lines and CD133 expression. The favorable characteristics of 68Ga-DOTA-LS7, such as convenient synthesis and specific uptake, warrant its further investigation for CD133 expression imaging.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
In conclusion, mesenchymal stem cells-derived secretome could be further explored for the management of Parkinson's disease.PMID:34553608 | DOI:10.2217/rme-2021-0018
Source: Regenerative Medicine - Category: Genetics & Stem Cells Authors: Source Type: research
This study provides new insights into the mechanisms and appropriate risk management of 4-NP.
Source: Journal of Applied Toxicology - Category: Toxicology Authors: Tags: RESEARCH ARTICLE Source Type: research
Dalton Trans., 2021, Accepted Manuscript DOI: 10.1039/D1DT02909F, PerspectiveYingsi Li, Boxin Liu, Hongdong Shi, Yi Wang, Qi Sun, Qianling Zhang With the highest incidence, breast cancer ranks as the leading cause of cancer deaths among women in the world. Tumor metastasis and is the major contributor of high mortality in... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Dalton Trans. latest articles - Category: Chemistry Authors: Source Type: research
g Yeng Looi Insight into cancer signaling pathways is vital in the development of new cancer treatments to improve treatment efficacy. A relatively new but essential developmental signaling pathway, namely Hedgehog (Hh), has recently emerged as a major mediator of cancer progression and chemoresistance. The evolutionary conserved Hh signaling pathway requires an in-depth understanding of the paradigm of Hh signaling transduction, which is fundamental to provide the necessary means for the design of novel tools for treating cancer related to aberrant Hh signaling. This review will focus substantially on the canonical Hh...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
Autophagy is a highly conserved process for maintaining cellular homeostasis. Upregulation of autophagy promotes metastasis by promoting the cancer stem cell state while also stimulating tumor cell migration and invasion. We hypothesized that autophagy upregulation would be critical for cancer stem cell maintenance as well as cellular migration and invasion in thyroid cancer.
Source: Surgery - Category: Surgery Authors: Source Type: research
More News: Biology | Government | Meat | Men | Science | Stem Cell Therapy | Stem Cells